Raymond James Financial
COYA icon

Raymond James Financial’s Coya Therapeutics COYA Stock Holding History

Raymond James Financial’s Portfolio COYA Stock Details COYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$59.8K Sell
10,225
-1,448
-12% -$6.71K ﹤0.01% 5236
2026
Q1 		$46K Buy
11,673
+693
+6% +$3.24K ﹤0.01% 5132
2025
Q4 		$63.7K Buy
+10,980
New +$66.7K ﹤0.01% 4989
2025
Q3 		– Sell
-1,980
Closed -$11.4K – 5332
2025
Q2 		$11.4K Buy
+1,980
New +$11.5K ﹤0.01% 5871

Other funds holding COYA

DCM
DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

Raymond James Financial's COYA Position: Q2 2026 in Review

Raymond James Financial reduced its Coya Therapeutics (COYA) stake by 12% in Q2 2026, selling an estimated $6.71K and leaving 10,225 shares worth $59.8K. The position accounts for ﹤0.01% of the portfolio, ranked #5236.

Raymond James Financial first reported a position in COYA in Q2 2025 and has held it in 4 quarters since. The position peaked at $63.7K in Q4 2025. 54 funds tracked by Wall St. Rank hold COYA as of Q2 2026.

  • Raymond James Financial held 10,225 shares of Coya Therapeutics worth $59.8K as of Q2 2026.
  • Raymond James Financial sold 1,448 Coya Therapeutics shares in Q2 2026, an estimated $6.71K.
  • Coya Therapeutics made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #5236 holding.
  • Raymond James Financial first reported a position in Coya Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • Raymond James Financial's Coya Therapeutics position peaked at $63.7K in Q4 2025.
  • 54 funds tracked by Wall St. Rank held Coya Therapeutics as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.